Biome Grow Inc.
Biome Grow Inc. (BIOIF) Stock Competitors & Peer Comparison
See (BIOIF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOIF | $0.00 | +0.00% | 204.3M | -0.02 | -$0.02 | N/A |
| MKKGY | $24.69 | +0.61% | 55B | 16.93 | $1.50 | +1.96% |
| MKGAF | $124.50 | +0.09% | 53.4B | 16.36 | $7.51 | +2.04% |
| TKPHF | $27.50 | +0.00% | 44.6B | 49.25 | $0.58 | +4.66% |
| HLNCF | $4.62 | -1.91% | 43B | 22.79 | $0.21 | +1.82% |
| IPSEY | $30.05 | -3.31% | 41.2B | 19.95 | $1.56 | +0.83% |
| SDZNY | $55.91 | -10.41% | 25.3B | -2932.50 | -$0.02 | +1.15% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.4B | -95.47 | -$0.15 | N/A |
| SGIOY | $8.87 | +0.21% | 15.2B | 13.15 | $0.68 | +1.78% |
Stock Comparison
BIOIF vs MKKGY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, MKKGY has a market cap of 55B. Regarding current trading prices, BIOIF is priced at $0.00, while MKKGY trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas MKKGY's P/E ratio is 16.93. In terms of profitability, BIOIF's ROE is -10.85%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, BIOIF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check MKKGY's competition here
BIOIF vs MKGAF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, MKGAF has a market cap of 53.4B. Regarding current trading prices, BIOIF is priced at $0.00, while MKGAF trades at $124.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas MKGAF's P/E ratio is 16.36. In terms of profitability, BIOIF's ROE is -10.85%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, BIOIF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check MKGAF's competition here
BIOIF vs TKPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, BIOIF is priced at $0.00, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TKPHF's P/E ratio is 49.25. In terms of profitability, BIOIF's ROE is -10.85%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, BIOIF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
BIOIF vs HLNCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HLNCF has a market cap of 43B. Regarding current trading prices, BIOIF is priced at $0.00, while HLNCF trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HLNCF's P/E ratio is 22.79. In terms of profitability, BIOIF's ROE is -10.85%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, BIOIF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check HLNCF's competition here
BIOIF vs IPSEY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, IPSEY has a market cap of 41.2B. Regarding current trading prices, BIOIF is priced at $0.00, while IPSEY trades at $30.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas IPSEY's P/E ratio is 19.95. In terms of profitability, BIOIF's ROE is -10.85%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, BIOIF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check IPSEY's competition here
BIOIF vs SDZNY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SDZNY has a market cap of 25.3B. Regarding current trading prices, BIOIF is priced at $0.00, while SDZNY trades at $55.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SDZNY's P/E ratio is -2932.50. In terms of profitability, BIOIF's ROE is -10.85%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, BIOIF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check SDZNY's competition here
BIOIF vs ESALY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, BIOIF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ESALY's P/E ratio is 20.54. In terms of profitability, BIOIF's ROE is -10.85%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, BIOIF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check ESALY's competition here
BIOIF vs TEVJF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, BIOIF is priced at $0.00, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, BIOIF's ROE is -10.85%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, BIOIF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
BIOIF vs SGIOY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SGIOY has a market cap of 15.2B. Regarding current trading prices, BIOIF is priced at $0.00, while SGIOY trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SGIOY's P/E ratio is 13.15. In terms of profitability, BIOIF's ROE is -10.85%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, BIOIF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check SGIOY's competition here
BIOIF vs SGIOF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, BIOIF is priced at $0.00, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, BIOIF's ROE is -10.85%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, BIOIF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
BIOIF vs BIOVF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, BIOIF is priced at $0.00, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas BIOVF's P/E ratio is 22.92. In terms of profitability, BIOIF's ROE is -10.85%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, BIOIF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
BIOIF vs IPSEF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, BIOIF is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas IPSEF's P/E ratio is 18.19. In terms of profitability, BIOIF's ROE is -10.85%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, BIOIF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
BIOIF vs SFOSF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SFOSF has a market cap of 8.8B. Regarding current trading prices, BIOIF is priced at $0.00, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, BIOIF's ROE is -10.85%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, BIOIF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
BIOIF vs ESALF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, BIOIF is priced at $0.00, while ESALF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ESALF's P/E ratio is 27.03. In terms of profitability, BIOIF's ROE is -10.85%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, BIOIF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
BIOIF vs ESAIY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ESAIY has a market cap of 8.4B. Regarding current trading prices, BIOIF is priced at $0.00, while ESAIY trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ESAIY's P/E ratio is 26.58. In terms of profitability, BIOIF's ROE is -10.85%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, BIOIF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check ESAIY's competition here
BIOIF vs GZPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, BIOIF is priced at $0.00, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, BIOIF's ROE is -10.85%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, BIOIF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
BIOIF vs HKMPF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HKMPF has a market cap of 5.8B. Regarding current trading prices, BIOIF is priced at $0.00, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HKMPF's P/E ratio is 15.80. In terms of profitability, BIOIF's ROE is -10.85%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, BIOIF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
BIOIF vs HKMPY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HKMPY has a market cap of 5.3B. Regarding current trading prices, BIOIF is priced at $0.00, while HKMPY trades at $51.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HKMPY's P/E ratio is 14.99. In terms of profitability, BIOIF's ROE is -10.85%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, BIOIF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
BIOIF vs SGFEF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, BIOIF is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SGFEF's P/E ratio is 25.02. In terms of profitability, BIOIF's ROE is -10.85%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, BIOIF and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
BIOIF vs WIBFF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, BIOIF is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, BIOIF's ROE is -10.85%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, BIOIF and WIBFF have similar daily volatility (0.00).Check WIBFF's competition here
BIOIF vs HLUBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HLUBF has a market cap of 4.5B. Regarding current trading prices, BIOIF is priced at $0.00, while HLUBF trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HLUBF's P/E ratio is 9.13. In terms of profitability, BIOIF's ROE is -10.85%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, BIOIF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
BIOIF vs HLBBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, BIOIF is priced at $0.00, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HLBBF's P/E ratio is 9.90. In terms of profitability, BIOIF's ROE is -10.85%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, BIOIF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
BIOIF vs SMDPY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SMDPY has a market cap of 3.8B. Regarding current trading prices, BIOIF is priced at $0.00, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SMDPY's P/E ratio is 24.15. In terms of profitability, BIOIF's ROE is -10.85%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, BIOIF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
BIOIF vs LVZPF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, BIOIF is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, BIOIF's ROE is -10.85%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, BIOIF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
BIOIF vs CHSYF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, BIOIF is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, BIOIF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
BIOIF vs ULIHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, BIOIF is priced at $0.00, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, BIOIF's ROE is -10.85%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, BIOIF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
BIOIF vs APNHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, BIOIF is priced at $0.00, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas APNHF's P/E ratio is 12.95. In terms of profitability, BIOIF's ROE is -10.85%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, BIOIF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
BIOIF vs INVVY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, BIOIF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas INVVY's P/E ratio is -62.42. In terms of profitability, BIOIF's ROE is -10.85%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, BIOIF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
BIOIF vs IZQVF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, BIOIF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, BIOIF's ROE is -10.85%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, BIOIF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
BIOIF vs DNPUF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, BIOIF is priced at $0.00, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas DNPUF's P/E ratio is 17.66. In terms of profitability, BIOIF's ROE is -10.85%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, BIOIF and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
BIOIF vs LBTSF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, BIOIF is priced at $0.00, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, BIOIF's ROE is -10.85%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, BIOIF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
BIOIF vs HMDCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, BIOIF is priced at $0.00, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, BIOIF's ROE is -10.85%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, BIOIF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
BIOIF vs APNHY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, APNHY has a market cap of 2.7B. Regarding current trading prices, BIOIF is priced at $0.00, while APNHY trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas APNHY's P/E ratio is 11.05. In terms of profitability, BIOIF's ROE is -10.85%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, BIOIF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
BIOIF vs HYPMY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HYPMY has a market cap of 2.7B. Regarding current trading prices, BIOIF is priced at $0.00, while HYPMY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HYPMY's P/E ratio is 20.52. In terms of profitability, BIOIF's ROE is -10.85%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, BIOIF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check HYPMY's competition here
BIOIF vs THCBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, BIOIF is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas THCBF's P/E ratio is -0.10. In terms of profitability, BIOIF's ROE is -10.85%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, BIOIF and THCBF have similar daily volatility (0.00).Check THCBF's competition here
BIOIF vs DMPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, BIOIF is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, BIOIF's ROE is -10.85%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, BIOIF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
BIOIF vs HTSUF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, BIOIF is priced at $0.00, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HTSUF's P/E ratio is 15.99. In terms of profitability, BIOIF's ROE is -10.85%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, BIOIF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
BIOIF vs LJUIF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, BIOIF is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, BIOIF's ROE is -10.85%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, BIOIF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
BIOIF vs CASBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CASBF has a market cap of 1.9B. Regarding current trading prices, BIOIF is priced at $0.00, while CASBF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CASBF's P/E ratio is -30.05. In terms of profitability, BIOIF's ROE is -10.85%, compared to CASBF's ROE of -0.04%. Regarding short-term risk, BIOIF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
BIOIF vs ARSUF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, BIOIF is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, BIOIF's ROE is -10.85%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, BIOIF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
BIOIF vs TSMRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, BIOIF is priced at $0.00, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TSMRF's P/E ratio is 8.21. In terms of profitability, BIOIF's ROE is -10.85%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, BIOIF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
BIOIF vs NPNKF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, BIOIF is priced at $0.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas NPNKF's P/E ratio is 7.82. In terms of profitability, BIOIF's ROE is -10.85%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, BIOIF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
BIOIF vs GTBIF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, GTBIF has a market cap of 1.7B. Regarding current trading prices, BIOIF is priced at $0.00, while GTBIF trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas GTBIF's P/E ratio is 34.45. In terms of profitability, BIOIF's ROE is -10.85%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, BIOIF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check GTBIF's competition here
BIOIF vs MITPF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, BIOIF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas MITPF's P/E ratio is -10.81. In terms of profitability, BIOIF's ROE is -10.85%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, BIOIF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check MITPF's competition here
BIOIF vs KARBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, BIOIF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas KARBF's P/E ratio is 262.50. In terms of profitability, BIOIF's ROE is -10.85%, compared to KARBF's ROE of N/A. Regarding short-term risk, BIOIF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
BIOIF vs EVOTF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, BIOIF is priced at $0.00, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas EVOTF's P/E ratio is -6.26. In terms of profitability, BIOIF's ROE is -10.85%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, BIOIF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
BIOIF vs CURLF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CURLF has a market cap of 1.5B. Regarding current trading prices, BIOIF is priced at $0.00, while CURLF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CURLF's P/E ratio is -5.97. In terms of profitability, BIOIF's ROE is -10.85%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, BIOIF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check CURLF's competition here
BIOIF vs NPPNY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, BIOIF is priced at $0.00, while NPPNY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas NPPNY's P/E ratio is 6.55. In terms of profitability, BIOIF's ROE is -10.85%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, BIOIF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
BIOIF vs SHEZF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, BIOIF is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, BIOIF's ROE is -10.85%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, BIOIF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
BIOIF vs CHIZF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, BIOIF is priced at $0.00, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, BIOIF's ROE is -10.85%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, BIOIF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
BIOIF vs KSPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, BIOIF is priced at $0.00, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, BIOIF's ROE is -10.85%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, BIOIF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
BIOIF vs GNMLF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, BIOIF is priced at $0.00, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, BIOIF's ROE is -10.85%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, BIOIF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
BIOIF vs SWGHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, BIOIF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, BIOIF's ROE is -10.85%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, BIOIF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
BIOIF vs TCNNF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TCNNF has a market cap of 1.1B. Regarding current trading prices, BIOIF is priced at $0.00, while TCNNF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TCNNF's P/E ratio is -7.06. In terms of profitability, BIOIF's ROE is -10.85%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, BIOIF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check TCNNF's competition here
BIOIF vs KKPCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, KKPCF has a market cap of 1.1B. Regarding current trading prices, BIOIF is priced at $0.00, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, BIOIF's ROE is -10.85%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, BIOIF and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
BIOIF vs BIOGY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, BIOGY has a market cap of 991.6M. Regarding current trading prices, BIOIF is priced at $0.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas BIOGY's P/E ratio is 33.66. In terms of profitability, BIOIF's ROE is -10.85%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, BIOIF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
BIOIF vs NIKA Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, BIOIF is priced at $0.00, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas NIKA's P/E ratio is N/A. In terms of profitability, BIOIF's ROE is -10.85%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, BIOIF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
BIOIF vs SHPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, BIOIF is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, BIOIF's ROE is -10.85%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, BIOIF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
BIOIF vs LVTTF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LVTTF has a market cap of 892.9M. Regarding current trading prices, BIOIF is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, BIOIF's ROE is -10.85%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, BIOIF and LVTTF have similar daily volatility (0.00).Check LVTTF's competition here
BIOIF vs EVRRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, EVRRF has a market cap of 889.1M. Regarding current trading prices, BIOIF is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, BIOIF's ROE is -10.85%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, BIOIF and EVRRF have similar daily volatility (0.00).Check EVRRF's competition here
BIOIF vs NRXCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, NRXCF has a market cap of 843.2M. Regarding current trading prices, BIOIF is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, BIOIF's ROE is -10.85%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, BIOIF and NRXCF have similar daily volatility (0.00).Check NRXCF's competition here
BIOIF vs TWAPF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, BIOIF is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, BIOIF's ROE is -10.85%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, BIOIF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
BIOIF vs CSWYF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, BIOIF is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, BIOIF's ROE is -10.85%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, BIOIF and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
BIOIF vs TRXPF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, BIOIF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, BIOIF's ROE is -10.85%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, BIOIF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
BIOIF vs YIHCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, BIOIF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, BIOIF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
BIOIF vs ELTP Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ELTP has a market cap of 621.1M. Regarding current trading prices, BIOIF is priced at $0.00, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ELTP's P/E ratio is -29.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, BIOIF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check ELTP's competition here
BIOIF vs TRSSF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, BIOIF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, BIOIF's ROE is -10.85%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, BIOIF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check TRSSF's competition here
BIOIF vs SWDCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, SWDCF has a market cap of 600.2M. Regarding current trading prices, BIOIF is priced at $0.00, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas SWDCF's P/E ratio is 93.88. In terms of profitability, BIOIF's ROE is -10.85%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, BIOIF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
BIOIF vs PKBFF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, PKBFF has a market cap of 545.1M. Regarding current trading prices, BIOIF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas PKBFF's P/E ratio is N/A. In terms of profitability, BIOIF's ROE is -10.85%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, BIOIF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
BIOIF vs AIHLF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, BIOIF is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, BIOIF's ROE is -10.85%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, BIOIF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
BIOIF vs CCHWF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, BIOIF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, BIOIF's ROE is -10.85%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, BIOIF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check CCHWF's competition here
BIOIF vs KHTRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, BIOIF is priced at $0.00, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, BIOIF's ROE is -10.85%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, BIOIF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
BIOIF vs PEXXF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, BIOIF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to PEXXF's ROE of N/A. Regarding short-term risk, BIOIF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
BIOIF vs BOIRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, BOIRF has a market cap of 416.7M. Regarding current trading prices, BIOIF is priced at $0.00, while BOIRF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas BOIRF's P/E ratio is 32.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, BIOIF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
BIOIF vs AGYTF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, BIOIF is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, BIOIF's ROE is -10.85%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, BIOIF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
BIOIF vs HUMDF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, BIOIF is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, BIOIF's ROE is -10.85%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, BIOIF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
BIOIF vs VRNOF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, VRNOF has a market cap of 345.3M. Regarding current trading prices, BIOIF is priced at $0.00, while VRNOF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas VRNOF's P/E ratio is -0.96. In terms of profitability, BIOIF's ROE is -10.85%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, BIOIF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check VRNOF's competition here
BIOIF vs GLASF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, GLASF has a market cap of 313M. Regarding current trading prices, BIOIF is priced at $0.00, while GLASF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas GLASF's P/E ratio is -68.89. In terms of profitability, BIOIF's ROE is -10.85%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, BIOIF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check GLASF's competition here
BIOIF vs CPHRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CPHRF has a market cap of 291.3M. Regarding current trading prices, BIOIF is priced at $0.00, while CPHRF trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CPHRF's P/E ratio is 31.58. In terms of profitability, BIOIF's ROE is -10.85%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, BIOIF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check CPHRF's competition here
BIOIF vs CRLBF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CRLBF has a market cap of 248.5M. Regarding current trading prices, BIOIF is priced at $0.00, while CRLBF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CRLBF's P/E ratio is -3.07. In terms of profitability, BIOIF's ROE is -10.85%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, BIOIF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check CRLBF's competition here
BIOIF vs BHCCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, BIOIF is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, BIOIF's ROE is -10.85%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, BIOIF and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
BIOIF vs PLNHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, BIOIF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, BIOIF's ROE is -10.85%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, BIOIF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check PLNHF's competition here
BIOIF vs PHCUF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, PHCUF has a market cap of 156.6M. Regarding current trading prices, BIOIF is priced at $0.00, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas PHCUF's P/E ratio is -293.74. In terms of profitability, BIOIF's ROE is -10.85%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, BIOIF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
BIOIF vs CBWTF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CBWTF has a market cap of 146.5M. Regarding current trading prices, BIOIF is priced at $0.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CBWTF's P/E ratio is 5.45. In terms of profitability, BIOIF's ROE is -10.85%, compared to CBWTF's ROE of +0.20%. Regarding short-term risk, BIOIF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check CBWTF's competition here
BIOIF vs JUSHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, JUSHF has a market cap of 137.7M. Regarding current trading prices, BIOIF is priced at $0.00, while JUSHF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas JUSHF's P/E ratio is -2.33. In terms of profitability, BIOIF's ROE is -10.85%, compared to JUSHF's ROE of +1.20%. Regarding short-term risk, BIOIF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check JUSHF's competition here
BIOIF vs COPHF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, BIOIF is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas COPHF's P/E ratio is -0.02. In terms of profitability, BIOIF's ROE is -10.85%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, BIOIF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check COPHF's competition here
BIOIF vs LOVFF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LOVFF has a market cap of 127.1M. Regarding current trading prices, BIOIF is priced at $0.00, while LOVFF trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LOVFF's P/E ratio is 13.90. In terms of profitability, BIOIF's ROE is -10.85%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, BIOIF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
BIOIF vs STMH Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, STMH has a market cap of 125.8M. Regarding current trading prices, BIOIF is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas STMH's P/E ratio is N/A. In terms of profitability, BIOIF's ROE is -10.85%, compared to STMH's ROE of -2.75%. Regarding short-term risk, BIOIF and STMH have similar daily volatility (0.00).Check STMH's competition here
BIOIF vs NWPN Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, BIOIF is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas NWPN's P/E ratio is -0.04. In terms of profitability, BIOIF's ROE is -10.85%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, BIOIF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check NWPN's competition here
BIOIF vs HLTRF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, HLTRF has a market cap of 116.2M. Regarding current trading prices, BIOIF is priced at $0.00, while HLTRF trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas HLTRF's P/E ratio is -6.47. In terms of profitability, BIOIF's ROE is -10.85%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, BIOIF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
BIOIF vs LPCUF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, BIOIF is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, BIOIF's ROE is -10.85%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, BIOIF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
BIOIF vs CNVCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, BIOIF is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, BIOIF's ROE is -10.85%, compared to CNVCF's ROE of -3.90%. Regarding short-term risk, BIOIF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
BIOIF vs AAWH Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, AAWH has a market cap of 106.3M. Regarding current trading prices, BIOIF is priced at $0.00, while AAWH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas AAWH's P/E ratio is -1.30. In terms of profitability, BIOIF's ROE is -10.85%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, BIOIF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check AAWH's competition here
BIOIF vs GRUSF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, GRUSF has a market cap of 98.4M. Regarding current trading prices, BIOIF is priced at $0.00, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas GRUSF's P/E ratio is -13.24. In terms of profitability, BIOIF's ROE is -10.85%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, BIOIF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check GRUSF's competition here
BIOIF vs BIOYF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, BIOYF has a market cap of 95.1M. Regarding current trading prices, BIOIF is priced at $0.00, while BIOYF trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas BIOYF's P/E ratio is 17.27. In terms of profitability, BIOIF's ROE is -10.85%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, BIOIF and BIOYF have similar daily volatility (0.00).Check BIOYF's competition here
BIOIF vs LRDSF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, LRDSF has a market cap of 84M. Regarding current trading prices, BIOIF is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, BIOIF's ROE is -10.85%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, BIOIF and LRDSF have similar daily volatility (0.00).Check LRDSF's competition here
BIOIF vs ABSCF Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, BIOIF is priced at $0.00, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, BIOIF's ROE is -10.85%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, BIOIF and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
BIOIF vs PLNH Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, PLNH has a market cap of 75.4M. Regarding current trading prices, BIOIF is priced at $0.00, while PLNH trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas PLNH's P/E ratio is -1.66. In terms of profitability, BIOIF's ROE is -10.85%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, BIOIF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOIF.Check PLNH's competition here
BIOIF vs EOFBY Comparison August 2025
BIOIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOIF stands at 204.3M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, BIOIF is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOIF currently has a P/E ratio of -0.02, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, BIOIF's ROE is -10.85%, compared to EOFBY's ROE of N/A. Regarding short-term risk, BIOIF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here